Britt Glaunsinger, PhD, Professor, Departments of Plant & Microbial Biology and Molecular & Cellular Biology, University of California, Berkeley; Class of 1963 Endowed Chair, University of California, Berkeley; HHMI Investigator, Howard Hughes Medical Institute. Recorded Oct. 29, 2020
The coronavirus pandemic has upended society and dramatically changed the face of scientific research. This unprecedented global shift towards the singular goal of understanding how this novel coronavirus works and how to stop it has contributed to a remarkably rapid and deep understanding of the viral lifecycle. In this context, Glaunsinger will describe the latest findings on how SARS-CoV-2 slips past our cells’ barriers, hijacks the cellular machinery, is amplified to form new progeny virions and escapes detection by the immune system. Glaunsinger will also highlight the viral components that are targets for therapeutic interventions and vaccine design, whose degrees of success may ultimately define the duration of this pandemic.
The Arntzen Grand Challenges Lecture series is inspired by Dr. Charles (Charlie) Arntzen, Founding Director of the ASU Biodesign Institute. Dr. Arntzen is internationally recognized for his novel applied research on the development of genetic strategies for using plants to manufacture pharmaceuticals and produce cost-effective vaccines or drugs to save lives around the world, especially in developing nations.
The Biodesign Institute at ASU delivers the future of nature-inspired scientific innovation today for the betterment of human health, community safety and global sustainability.
Follow us on our social media channels:
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
